Trospium-Releasing Intravesical System (TAR-302-5018)

DRUG2 trials

Sponsors

Taris Biomedical LLC

Conditions

Idiopathic Overactive Bladder With Urinary IncontinenceNeurogenic Detrusor Overactivity

Phase 1

Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive Bladder

CompletedNCT03109379

Taris Biomedical LLCIdiopathic Overactive Bladder With Urinary Incontinence

Start: 2017-04-04End: 2019-09-27Updated: 2020-01-13

Safety and Tolerability of TAR-302-5018 in Subjects With Neurogenic Detrusor Overactivity Resulting From Spinal Cord Injury

CompletedNCT03168828

Taris Biomedical LLCNeurogenic Detrusor Overactivity

Start: 2017-04-24End: 2018-07-26Updated: 2020-01-13